Launch Therapeutics logo — Fully invested in late-stage innovation

Launch Therapeutics

Fully invested in late-stage innovation

Founded 2022 United States Boston, United States 36 employees Private Equity Biopharma, Biotechnology +1

General Information

Company Name Launch Therapeutics
Founded Year 2022
Location United States Boston, United States
Employees 36
Industries Biopharma, Biotechnology, Clean Energy
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with Launch Therapeutics. To contact Launch Therapeutics, visit launchtx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Launch Therapeutics

Launch Therapeutics is a biotech and biopharma solutions provider fully dedicated to late-stage innovation. The company offers a range of tailored collaboration models and expertise in regulatory strategy, clinical development, manufacturing, and commercialization. Backed by renowned investors The Carlyle Group and Abingworth, Launch Tx was established in 2022 with a mission to expedite the approval and delivery of therapies. The company's emphasis on connecting drug candidates with development funding and its vision of redefining late-stage development positions it poised for significant impact. With a focus on Biopharma, Biotechnology, and Clean Energy, Launch Tx's influence extends from its headquarters in the United States, evident in its recent Private Equity Round investment in partnership with industry giants, The Carlyle Group and Abingworth on 11th April 2022.

Taxonomy: clinical development, drug development, pharmaceutical industry, biotech industry, late-stage clinical programs, regulatory success, capital access, clinical co-development, in-licensing, global network, partnering, patient-centric, life sciences, investment-backed

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round Undisclosed 2
The Carlyle Group, Abingworth
11 Apr 2022

Launch Therapeutics Alternatives & Competitors

Launch Therapeutics vs

Clinical Research, Regulatory & Market Access

4 employees
Biotechnology
Launch Therapeutics vs

The Strength of a Trusted Partnership

Series B
12 employees
Biopharma, Biotechnology
Launch Therapeutics vs
Clinical Trial Bid
Clinical Trial Bid United States

The First Ever Clinical Trial Tenders Hub

8 employees
Biopharma, Biotechnology

FAQ About Launch Therapeutics

Fully invested in late-stage innovation
Launch Therapeutics was founded in 2022.
Launch Therapeutics is headquartered in Boston, United States.
Launch Therapeutics operates in Biopharma, Biotechnology and Clean Energy. Its work centres on clinical development, drug development, pharmaceutical industry and biotech industry.
Launch Therapeutics has approximately 36 employees.
Launch Therapeutics has completed 1 funding round. The latest funding stage is Private Equity.
Top alternatives and competitors to Launch Therapeutics include Wound Market Consulting, Arrivo BioVentures LLC, Clinical Trial Bid, Quris AI, JNPMEDI. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Launch Therapeutics and Wound Market Consulting are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Launch Therapeutics, https://bouncewatch.com/company/launch-therapeutics, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes